Efficacy of steroid therapy for prevention of recurrent cerebral amyloid angiopathy-related hemorrhage.
Not Applicable
- Conditions
- Cerebral amyloid angiopathy
- Registration Number
- JPRN-UMIN000011623
- Lead Sponsor
- Aizawa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have met these exclusion criteria should be excluded. Age is younger than 41 years old or older than 86 years old when informed consent was obtained. Patients who have uncontrolled hypertension (systolic blood pressure>=160mmHg or diastolic blood pressure>=100mmHg), taken antithrombotic medication (antiplatelet or anticoagulant drug), abnormal glucose tolerance (HbA1c>=6.5%(NGSP)). Patients who may have difficulty in adherence to continuous and regular medication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The subjects who had been diagnosed as CAA and agreed with administration of corticosteroid were randomly divided into two groups, 2.5mg and 10mg prednisolone. We will evaluate the time from baseline study to re-bleeding resulting from CAA within 18 months observational period.
- Secondary Outcome Measures
Name Time Method